Tillotts was established in London in the 1950s as a family-owned pharmacy known as J.B. Tillott Ltd Chemists. The business gradually expanded to become a wholesaler and then an importer of pharmaceutical products, in particular gastric ulcer treatments.
During the 1960s, after the foundation of Tillotts Laboratories Ltd, Tillotts became the UK market leader in gastric ulcer treatments. The company acquired the worldwide rights to Asacol™ and Colpermin™, two patent-protected products for the treatment of inflammatory bowel disease and irritable bowel syndrome, respectively.
Since then, the company has continued to expand in the field of gastrointestinal (GI) diseases and has focused on building its network of affiliates and gastroenterology-focused partners to create a strong, trusted partner in GI-health. In 2015, Tillotts acquired from AstraZeneca the global rights (ex-USA) for Entocort™, a medicinal product indicated for the treatment of Crohn’s disease and, in some markets, ulcerative colitis, that is complementary to Asacol™.
Please find the full history of Tillotts below.